Sai Life Sciences Ltd. on Monday, October 27, announced that it is setting up a new research and development ( R&D ) block for chemical, manufacturing, and controls processing Hyderabad campus. The five-storeyed facility, designed as a green building, is expected to be ready by September 2026.

Sai Life Sciences said the expansion will strengthen its position as a preferred partner for integrated drug development, aligned with the growing demand for end-to-end, partnership-driven solutions that deliver on both quality and timelines.

The investment is part of the company’s planned capital expenditure, reflecting strong business momentum, a robust late-stage development pipeline, and increasing demand for scalable capacity across CMC development and manufacturing.

Krishna Kanumuri, CEO

See Full Page